ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,484.77
2.03%
US Tech 100
18,744.00
3.09%
Dow Jones
40,093.40
1.23%
Brent Oil
65.77
0.64%
Bitcoin
93,570.30
-0.18%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. UCB SA (UCB) Quote

UCB SA

UCB SA (UCB)

United Communty Banks Inc
147.35
0.60
(0.41%)
Closed April 24 11:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
147.35
Bid
147.00
Ask
148.10
Volume
204,753
143.15 Day's Range 147.35
118.10 52 Week Range 198.95
Market Cap
28.66B
Previous Close
146.75
Open
144.30
Last Trade
97
@
147.35
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
303,050
Shares Outstanding
194,506,000
Dividend Yield
-
PE Ratio
26.91
Earnings Per Share (EPS)
5.48
Revenue
5.61B
Net Profit
1.07B

About UCB SA

Sector
Pharmaceutical Preparations
Industry
Chemicals & Allied Products
Website
www.ucb.com
Headquarters
Brussels, Brussels-capital Region, Bel
Founded
1928
UCB SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker UCB. The last closing price for UCB was 146.75 €. Over the last year, UCB shares have traded in a share price range of 118.10 € to 198.95 €.

UCB currently has 194,506,000 shares outstanding. The market capitalization of UCB is 28.54 € billion. UCB has a price to earnings ratio (PE ratio) of 26.91.

Ask ADVFN Intelligence (AI)

UCB Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
19.26.6594281578138.15147.35134.6329659141.68404616DE
4-18.75-11.2883804937166.1169129.35358471147.080565DE
12-44.15-23.0548302872191.5196.85129.35303050170.14399965DE
26-26.85-15.4133180253174.2198.95129.35253639175.86176265DE
5225.8521.2757201646121.5198.95118.1243886160.17794578DE
15639.136.1200923788108.25198.9565.4267973105.86832413DE
26063.9776.721036219783.38198.9565.4278941100.80938246DE

UCB - Frequently Asked Questions (FAQ)

What is the current UCB share price?
The current share price of UCB is 147.35 €
How many UCB shares are in issue?
UCB has 194,506,000 shares in issue
What is the market cap of UCB?
The market capitalisation of UCB is EUR 28.54B
What is the 1 year trading range for UCB share price?
UCB has traded in the range of 118.10 € to 198.95 € during the past year
What is the PE ratio of UCB?
The price to earnings ratio of UCB is 26.91
What is the cash to sales ratio of UCB?
The cash to sales ratio of UCB is 5.11
What is the reporting currency for UCB?
UCB reports financial results in EUR
What is the latest annual turnover for UCB?
The latest annual turnover of UCB is EUR 5.61B
What is the latest annual profit for UCB?
The latest annual profit of UCB is EUR 1.07B
What is the registered address of UCB?
The registered address for UCB is 60, ALLEE DE LA RECHERCHE, BRUSSELS, BRUSSELS-CAPITAL REGION, B-1070
What is the UCB website address?
The website address for UCB is www.ucb.com
Which industry sector does UCB operate in?
UCB operates in the CHEMICALS & ALLIED PRODUCTS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ATOAtos SE
34.60 €
(988,471.43%)
880.24k
ALALOAcheterLouerFR
0.0005 €
(25.00%)
262.64M
DGBDGB Group NV
0.51 €
(22.30%)
209.96k
SIGHTGenSight Biologics S.A.
0.265 €
(15.97%)
361.98k
XFABX FAB Silicon Foundries SE
4.784 €
(13.20%)
619.56k
DMSBSDiagnostic Medical Systems
0.0035 €
(-50.00%)
390
FPGUnion Tech Info
0.119 €
(-45.41%)
12.01k
MLSTRStreit Mecanique
9.85 €
(-39.20%)
232
FLOWFlow Traders Ltd
23.94 €
(-20.83%)
2.2M
MLSMLSmalto
0.013 €
(-18.75%)
16.02k
ALALOAcheterLouerFR
0.0005 €
(25.00%)
262.64M
ALEUPEuroplasma
0.0153 €
(4.08%)
82.59M
BCPBanco Comercial Portugues SA
0.5574 €
(-1.03%)
56.51M
ALVERVergnet
0.0007 €
(0.00%)
47.54M
ALHPIHopium SA
0.001 €
(-9.09%)
36.01M

Discussion

View Full Feed
dia76ca dia76ca 2 minutes ago
Now that Dr. Gabelle is on board is a good time to review what she said in her Dec.12, 2024 presentation. She said that the Anavex drugs autophagy target extends to ALL neurodegenerative diseases ! WOW !
https://drive.google.com/file/d/1rB6b45TvqhP63RUYMSTA-oMKRnuumCzA/view
AVXL
ron_66271 ron_66271 2 minutes ago
New Filings on LIBOR Docket.

FNMA and FMCC are listed.

Yes, the Derivative Writers own FNMA and FMCC Money.

https://www.docketbird.com/court-cases/In-re-Libor-Based-Financial-Instruments-Antitrust-Litigation/nysd-1:2011-md-02262


FMCC
bigstocksnbonds bigstocksnbonds 3 minutes ago
Yes fun!!!!
blackhawks blackhawks 3 minutes ago
New American Apple iPhone assembly line. Here's your screwdriver, influence those tiny screws.
cashclan cashclan 3 minutes ago
That is a little



Over the top ...destroyed ? Ha!

I know $17 to $10 is the real RANT but with the Chinese market collapsing and this was before Trump you might see $6..as they would rather have them eating tree bark than feed their 1.4 billion.
janice shell janice shell 3 minutes ago
Can you explain how it is that in the past couple of years, "common sense" has come to mean the opposite of what it meant for the past few centuries?
CommodityCoverage CommodityCoverage 3 minutes ago
Doubling down on its vision to become a leading gold-copper-silver explorer in Mexico, Defiance Silver (DEF.v DNCVF) is advancing two flagship projects while expanding into one of North America’s hottest copper belts in acquiring Green Earth Metals

With resource updates underway at Za
DEF
europa7 europa7 3 minutes ago
Healthcare use cases...Hedera...

Healthcare Organizations Must Secure Identities as Social Engineering Attacks Increase
"...CrowdStrike’s new Global Threat Report finds voice phishing is up, China and North Korea are finding their way into the cloud, and more..."
Apr 10
HBARUSD
BOREALIS BOREALIS 3 minutes ago
Trump’s Job Rating Drops, Key Policies Draw Majority Disapproval as He Nears 100 Days

https://www.pewresearch.org/wp-content/uploads/sites/20/2025/04/pp_2025-4-23_trump-100-days_00-03.png

https://www.pewresearch.org/politics/2025/04/23/trumps-job-rating-drops-key-polici
Truthsocial Truthsocial 3 minutes ago
That's why you are here right...
And also I've seen tickers go from where RDGL is currently to dollars within 24 hrs and never look back at the skater behind...

Let's go RDGL
RDGL
Musical Shares Musical Shares 4 minutes ago
Oh my. I can see you are not familiar with toxic funding, huh?

Let me highlight that once again:

The Company reissued a convertible redeemable note to AES Capital Management, LLC in the original principal amount of $210,000. The note matures on March 8, 2023. The note
PSWW
CommodityCoverage CommodityCoverage 4 minutes ago
Soleno Therapeutics turned a rare disease FDA approval into a $3B surge—jumping from $4 to $72. Now, Thiogenesis Therapeutics (TTI.v TTIPF) is poised to replicate this run with a Phase 2-ready treatment for MELAS and a fast-track regulatory path already in place.

Soleno showed the ma
TTI
devil dog 96 devil dog 96 4 minutes ago
The sad part is I did not get any of the $8 in shares that sold today. 😢 I'm not the only one BID sitting looking for more shares here as we saw today. 👀 Not sure who else would be trying to load now when this company has not done any marketing since 2018. Where is the new interest
ATMH
noradio noradio 4 minutes ago
I've never owned this stock.
FITY
SSKILLZ1 SSKILLZ1 5 minutes ago
~~COMPX 4/25/2025~~~~~~~

Previous Close

17166.04 +457.99

16900 SSKILLZ1
COMP
navycmdr navycmdr 6 minutes ago
very simple - EPS - which is the most

basic valuation of a companies value

until the Govt releases the GSEs from

holding them in 17 year Hostage --

and they are back on the NYSE that

has legit enforced rules & standards
FNMA
dennisdave dennisdave 6 minutes ago
if the MHRA believed the compassionate care program wasn’t benefiting patients, they should’ve suspended it.

mmm there have been compassionate care programs that ran before and after the MHRA dismissed treatment. So not really. Compassionate care programs are allowed when its safe for
NWBO
royal1 royal1 6 minutes ago
Been asking myself that same question but i see you’re still posting.
HMBL
penguin007 penguin007 7 minutes ago
As I'm reading through the posts here, I'm not finding any credible evidence to support any of these negative claims made against Josh, and/or ZHUD?! Why would anyone exert all this time and effort posting all this BS, and with no proof to support any of these false claims. Anyway, who really cares
ZHUD
ORBAPU ORBAPU 7 minutes ago
Amarin MarketEdge Today: NeutralStock shows Strongly Improving Conditions. SCORE = 4 
If you are Short this stock, consider covering or monitor stock closely. 
Stock is an Early Entry Buy Candidate if stock closes above 10.16
On 04/24/2025, The stock is outperforming the market
AMRN
dennisdave dennisdave 8 minutes ago
Welcome. Now, I’m going to say something concerning—again—which I’ve mentioned here a few times already.

IF Femke is right and this drags on beyond June, I don’t think it would be because the application is being dismissed. Rather, I suspect it might be because NWBO was so stupid, rec
NWBO
elks elks 9 minutes ago
Agreed
TWOH
glenn1919 glenn1919 10 minutes ago
SES......................................a/h
SES

Your Recent History

EU
UCB
UCB
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads